The present study deals with a brief overview of the comparative study of quality requirements for in-process and finished products quality control tests of the Indian Pharmacopeia (IP), British Pharmacopeia (BP) and United States Pharmacopeia (USP) for some conventional dosage forms. The concept of total quality control test refers to the process of striving to produce a quality product by a series of measures, requiring an organised effort in order to eliminate errors at every stage in the production. Shilpi Khattri, Balamuralidhara V. and T.M. Pramod Kumar, of JSS College of Pharmacy, explain.
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Pharmacopoeial Comparison of In-process & Finished Product Quality Control Tests for Parenterals: IP, BP & USP
